FABP4 and non-small cell lung carcinoma: Similarly, high FABP4 expression was detected in 60.14% (169/281) of NSCLC cancerous tissue samples significantly higher than 8.26% (10/121) detected in adjacent non-cancerous tissues (χ2=92.156, P<0.001).